Parts of this work have been previously presented at the XIXth International AIDS Conference, 22–27 July 2012, Washington, DC (Abstract MOPE085) and the 11th International Congress on Drug Therapy in HIV Infection, 11–15 November 2012, Glasgow, UK (Abstract P58).
Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy†
Version of Record online: 5 JUN 2013
© 2013 British HIV Association
Volume 14, Issue 9, pages 556–562, October 2013
How to Cite
Cervero, M., Agud, J., Torres, R., García-Lacalle, C., Alcázar, V., Jusdado, J. and Moreno, S. (2013), Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy. HIV Medicine, 14: 556–562. doi: 10.1111/hiv.12049
- Issue online: 4 SEP 2013
- Version of Record online: 5 JUN 2013
- Manuscript Accepted: 18 APR 2013
- 11The rapidly evolving research on vitamin D among HIV-infected populations. Curr Infect Dis Rep 2011; 13: 83–93., .
- 15Change in Vitamin D levels smaller of development of severe Vitamin D Deficiency lower among HIV-1 infected, Treatment-naive adults receiving TMC278 compared with EFV: 48-weeks result from the Phase III ECHO trial [O].1014]. 18th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February-March 2011., , et al.
- 18Panel on Clinical. Practices for the treatment of HIV infection. Spanish Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Consensus document GESIDA and PNS on antiretroviral treatment in adults, December 29, 2010. Available at www.gesida-seimc.org/pcientifica/fuentes/DcyRc/gesidadcyrc2012-Documentoconsenso-TAR-adulto-verordenador.pdf.
- 21Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982; 8263: 74–76., , et al.